TradeWinds23d
Braemar operations head Tris Simmonds quits role with replacement lined up
Braemar’s second-in-command is leaving the company. Tris Simmonds is stepping down from his role as chief operating officer at the UK shipbroker with immediate effect. James Gundy’s Braemar ...
FierceBiotech24d
Tris' next-gen pain drug completes trio of clinical wins, setting up push to FDA
Tris Pharma’s opioid alternative has scored a third win in a trio of clinical trials, providing the biotech with the data needed to take the pain relief drug to the FDA this year. The latest ...
BioPharma Dive25d
Tris to ask for approval of dual-acting pain drug
On Thursday, Tris Pharma released data from a clinical trial of about 240 people who had undergone bunion removal, a notoriously painful operation. Results showed that, over a two-day period post ...
clinicaltrialsarena25d
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial
Tris Pharma has announced positive data from two Phase III trials of cebranopadol, as well as positive data from a human abuse potential (HAP) study to compare the therapy against various opioids.